← All stocks

GALECTIN THERAPEUTICS INC

GALT Net buying

CIK 0001133416 #3361 in the set updated 17 Sep 2026

Bought (120 mo)

$21.12M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$24.76M

$595.80K on a plan · $11.21M straight out of an exercise

Sold at will

$12.95M

66 of 155 sales

Net

−$3.64M

+$8.17M against sales at will

By person

16 insiders · 254 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Uihlein Richard E

Director

$20.51M (7)

—

+$20.51M

55,074,229

$282.27M

+325.1%

10X Fund, L.P. entity

10% owner

—

$7.20M (42)

−$7.20M

11,385,227

$58.35M

+30.5%

CZIRR JAMES C

10% owner

—

$5.11M (16)

−$5.11M

15,907,874

$81.53M

−1.4%

CALLICUTT JACK W

Chief Financial Officer

$15.36K (2)

$4.00M (29) scheduled

−$3.98M

7,614

$39.02K

+504.3%

Shlevin Harold H.

Director

$7.54K (1)

$3.83M (24) scheduled

−$3.83M

26,123

$133.89K

−64.4%

Jamil Khurram

Chief Medical Officer

—

$1.45M (18) scheduled

−$1.45M

$0.00

—

TRABER PETER G

President & CEO

—

$1.16M (2) scheduled

−$1.16M

107,333

$550.10K

0.0%

Rubin Marc

Director

$12.97K (1)

$739.77K (5) scheduled

−$726.80K

13,581

$69.61K

−72.0%

LEWIS JOEL

President and CEO

$79.47K (7)

$759.19K (12) scheduled

−$679.73K

834,592

$4.28M

+3,459%

AMELIO GILBERT F

Director

—

$379.20K (4)

−$379.20K

60,614

$310.66K

+8.3%

FREEMAN KEVIN D

Director

$308.33K (31)

—

+$308.33K

192,269

$985.42K

+197.7%

ELDRED KARY

Director

$54.22K (13)

—

+$54.22K

70,107

$359.31K

+60.8%

Zordani Richard A. Jr.

Director

$50.36K (8)

—

+$50.36K

44,083

$225.93K

+202.3%

OMENN GILBERT S

Director

$79.51K (1)

$116.59K (2)

−$37.07K

66,769

$342.20K

−1.2%

ZUCCONI THEODORE DANIEL

Director

$2.27K (1)

$14.32K (1) scheduled

−$12.05K

1,083

$5.55K

+1,205%

Schwartz Elissa J.

Director

$2.00K (1)

—

+$2.00K

1,000

$5.13K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Jamil Khurram

6 Jan 2026

Chief Medical Officer

Sold on a plan

21,446

$3.65

$78.20K

CALLICUTT JACK W

6 Jan 2026

Chief Financial Officer

Sold on a plan

20,354

$3.67

$74.70K

LEWIS JOEL

6 Jan 2026

President and CEO

Sold on a plan

37,698

$3.58

$134.85K

Jamil Khurram

5 Jan 2026

Chief Medical Officer

Sold on a plan

25,499

$3.90

$99.41K

CALLICUTT JACK W

5 Jan 2026

Chief Financial Officer

Sold on a plan

25,732

$3.90

$100.30K

LEWIS JOEL

5 Jan 2026

President and CEO

Sold on a plan

27,731

$3.91

$108.34K

Showing 250 of 254 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 388

Amendments (4/A) skipped 24

Filings about a different issuer 0

Unreadable filings 0

Joint filings 36

Sales on a Rule 10b5-1 plan 6

Sales straight out of an exercise 83

Sales at will 66

Transactions with no price 0

Shares from compensation/vesting 46,633,147

Sales filed before the plan box existed 58

History held since 24 Oct 2016